European Union - English - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

European Union - English - EMA (European Medicines Agency)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologicals - sheep, cattle - sheepactive immunisation against bluetongue virus serotype 8 to prevent viraemia and to reduce clinical signs.onset of immunity: 20 days after second dose.duration of immunity: 1 year after second dose.cattleactive immunisation against bluetongue virus serotype 8 to prevent viraemia.onset of immunity: 31 days after second dose.duration of immunity: 1 year after second dose.

Australia - English - Department of Health (Therapeutic Goods Administration)

direct healthcare group pty ltd - 12330 - lift, patient transfer, mobile - floor lift systems are indoor movable and portable units which together with approved accessories assist in lifting and/or transferring users in a seated or supine position, over short distances between two points.

Australia - English - Department of Health (Therapeutic Goods Administration)

direct healthcare group pty ltd - 15693 - transfer aid, person, - sit to stand is intended to support a person with disability (impaired mobility, strength, balance), via self-raising mechanism, from a laying to sitting, sitting to standing positioning or sitting transfers.

European Union - English - EMA (European Medicines Agency)

gilead sciences ireland uc - tenofovir alafenamide fumarate - hepatitis b - antivirals for systemic use, - vemlidy is indicated for the treatment of chronic hepatitis b in adults and adolescents (aged 12 years and older with body weight at least 35 kg).,

European Union - English - EMA (European Medicines Agency)

gilead sciences ireland uc - elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infections - antivirals for systemic use, - genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (hiv 1) without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir.,

Australia - English - Department of Health (Therapeutic Goods Administration)

quintessa holdings pty ltd - 35038 - electrode, foetal scalp - sterile, single use electrode intended to be attached to the fetal scalp by healthcare professionals during delivery surveillance. for use on patients requiring fetal heart rate monitoring during labor.